Cervical cancer vaccine available soon in US

The first vaccine against cervical cancer will be available in the US to girls as young as nine later this month.

Cervical cancer vaccine available soon in US

The first vaccine against cervical cancer will be available in the US to girls as young as nine later this month.

Its manufacturer, Merck, is already taking orders for Gardasil. The three-shot series costs $360 (€284.65).

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited